拔罐辅助治疗肥胖型2型糖尿病临床疗效观察

Clinical Effectiveness of Adjunctive Therapy Using Cupping in Treating Patients with Obesity and Type 2 Diabetes Mellitus

目的探讨拔罐减肥治疗对肥胖型2型糖尿病(T2DM)患者体质量、内脏脂肪量、血糖、血脂及胰岛素抵抗的影响。方法 选取70例肥胖型T2DM患者,均采用基础胰岛素治疗控制血糖,随机分为A组(35例,联合拔罐疗法)和B组(联合口服二甲双胍),两组患者治疗观察3个月,记录两组治疗前后患者的体质量、体质指数(BMI)、血糖、糖化血红蛋白(HbA1c)、血脂(总胆固醇、三酰甘油、低密度脂蛋白)、空腹胰岛素水平,胰岛素抵抗指数(HOMA-IR)的变化,并进行统计学分析。结果两组治疗后患者的体质量、BMI、血糖、HbA1c、血脂、空腹胰岛素水平,HOMA-IR均显著改善(P<0.05);两组间比较:A组患者腹内脂肪面积较B组显著降低,差异有统计学意义(P<0.05)。结论拔罐辅助治疗可以有效改善肥胖型T2DM患者的体质量、内脏脂肪量及胰岛素抵抗,从而辅助降低血糖及血脂水平,且无药物的不良反应,安全性高。

Objective To explore the clinical effectiveness of adjunctive therapy using cupping in treating patients with obesity and type 2 diabetes mellitus（T2DM）. Methods Totally 70 patients with obesity and T2DM were enrolled in this study.Their blood sugar was controlled by basic insulin therapy.Patients were equally randomized into two groups based on the application of adjunctive therapy：Group A,treated by cupping;and Group B,treated by metformin.The changes of body weight,body mass index（BMI）,blood sugar,glycosylated hemoglobin（HbA1c）,total cholesterol（TC）,triglyceride（TG）,low density lipoprotein cholesterol（LDL-C）,fasting plasma glucose（FPG）,HOMA-IR were mearused and compared before and after treatment. Results All the parameters were significantly improved in both two groups after the treatment（P0.05）.The reduction of visceral fat in group A was significantly more remarkable than in group B（P0.05）. Conclusion Cupping can effectively improve the body weight,BMI,and HOMA-IR and lower blood suger and fat levels without notable adverse effect.